Publication date: 9 November 2026 Source: JACC: Cardiovascular Interventions, Volume 19, Issue 21 Author(s): Mahesh V. Madhavan, Allan Schwartz, Brian R. Lindman, Philippe Pibarot, David J. Cohen, J. Bradley Oldemeyer, Vasilis Babaliaros, William F. Fearon, David Daniels, Adnan Chhatriwalla, Clifford J. Kavinsky, Pinak Shah, Molly Szerlip, Thom Dahle, Kashish Goel, William O'Neill, Raj Makkar, Charles Davidson, Tej Sheth, Paul Sorajja
Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial. // JACC: Cardiovascular Interventions. – URL: https://www.sciencedirect.com/science/article/pii/S193687982602409X?dgcid=rss_sd_all
Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial. JACC: Cardiovascular Interventions. https://www.sciencedirect.com/science/article/pii/S193687982602409X?dgcid=rss_sd_all
“Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial.” JACC: Cardiovascular Interventions.
@article{article50820,
title = {Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial},
journal = {JACC: Cardiovascular Interventions},
url = {https://www.sciencedirect.com/science/article/pii/S193687982602409X?dgcid=rss_sd_all}
}